Skip to content

Telemedicine Notifications With Machine Learning for Postoperative Care

Telemedicine Notifications With Machine Learning for Postoperative Care

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03974828
Acronym
ODIN-Report
Enrollment
0
Registered
2019-06-05
Start date
2025-10-06
Completion date
2025-10-06
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Hospital Mortality, Perioperative/Postoperative Complications, Surgery--Complications

Keywords

Telemedicine, Anesthesia Control Tower, Machine Learning, Forecasting Algorithms, Randomized Controlled Trial, PACU

Brief summary

The ODIN-Report study will be a randomized controlled trial of the effect of providing machine learning risk forecasts to providers caring for patients immediately after surgery on serious complications. The complications studied will be ICU admission or death on wards, acute kidney injury, and hospital length of stay.

Detailed description

This will be a single center, randomized, controlled, pragmatic clinical trial. The investigators will screen surgical patients enrolled in TECTONICS (NCT03923699) and randomized to intraoperative contact. Near the end of the operation, the investigators will calculate the same machine learning risk forecasts of major complications as TECTONICS, and enroll patients if all of the following are true: (1) No ICU admission is intended (2) ML mortality risk forecast is in top 15% of historical PACU patients. Patients will be randomized 1:1:1 to no contact, brief contact, and full contact. The postoperative provider (PACU physician, anesthesiologist, ward clinician) will be notified before arrival of the risk forecast in the contact groups, and in the full contact group an additional set of explanatory ML outputs will be provided. The intention-to-treat principle will be followed for all analyses.

Interventions

DEVICEAnesthesia Control Tower Notification

Real-time data will be monitored through the AlertWatch system as well as the electronic health record. Risk forecasts of adverse events (30 day mortality, acute kidney injury, postoperative delirium, respiratory failure), PACU length of stay, and hospital length of stay will be generated by a machine learning algorithm. Additional outputs identifying the most important predictors and their effects will be combined with risk forecasts to form a report card.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

1:1:1 randomization between standard of care (no contact), postoperative contact (brief), postoperative contact (long).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled in TECTONICS Study (ID 201903026, NCT03923699), in OR randomized to contact * workweek hours * preoperative assessment completed * estimated risk of mortality in top 15% of historical PACU patients

Exclusion criteria

* Not enrolled in TECTONICS Study * Operating room randomized to non-contact in TECTONICS * Planned ICU admission

Design outcomes

Primary

MeasureTime frameDescription
Unplanned ICU admission7 days post-opAdmission to a "critical care" bed regardless of rationale or duration at any point in the follow up time frame. Patients who expire without transfer to ICU will be marked as positive.

Secondary

MeasureTime frameDescription
Acute Kidney Injury7 days post-opPostoperative laboratory values and urine output will be used to calculate Kidney Disease Improving Global Outcomes grades of acute kidney injury. Where unavailable, baseline Glomerular filtration rate will be assumed to be age, sex, and body size normal.
Hospital length of stay30 days post-opThe duration in days between end of anesthesia care and discharge from the performing hospital.

Contacts

PRINCIPAL_INVESTIGATORChristopher R King, MD, PhD

Washington University School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026